You're viewing a public preview of GamaMabs Pharma - AMHR2 Antibody Technology Sign up free to access full investment history, financials, executives & more

GamaMabs Pharma - AMHR2 Antibody Technology

Active
Toulouse,  France
Sector: Life Science Entity: Private
2
Transactions
Sign up to view
$5M
Deal Value
Sign up to view
About GamaMabs Pharma - AMHR2 Antibody Technology
Available information shows that GamaMabs Pharma - AMHR2 Antibody Technology operates in the Life Science sector. GamaMabs Pharma - AMHR2 Antibody Technology operates within the Life Science industry. The company is headquartered in Toulouse.
Investors
Current Investors
Exelixis, Inc. ••••••••
Past Investors
•••••••• ••••••••
View Full Investor List
Sign up to see all current & past investors with deal dates and transaction details
Investment Details
2 Transactions
Trans. IDInvestment DateExit DateInvestor(s)Deal Size (M)Seller(s)
Access 2 Transactions
Sign up to view the full investment history — dates, deal sizes, investors & sellers
GamaMabs Pharma - AMHR2 Antibody Technology M&A Activity
# Company Transaction Date Close Date Sector Country
View M&A Acquisitions
Sign up to explore the full acquisition & merger history
Key Executives & Professionals
View Executives & Professionals
Sign up to access board members, senior management & key contacts
Frequently Asked Questions
What does GamaMabs Pharma - AMHR2 Antibody Technology do?
Available information shows that GamaMabs Pharma - AMHR2 Antibody Technology operates in the Life Science sector. GamaMabs Pharma - AMHR2 Antibody Technology operates within the Life Science industry. The company is headquartered in Toulouse.
Where is GamaMabs Pharma - AMHR2 Antibody Technology headquartered?
GamaMabs Pharma - AMHR2 Antibody Technology is headquartered in Toulouse, France.
When was GamaMabs Pharma - AMHR2 Antibody Technology founded?
Founded year information for GamaMabs Pharma - AMHR2 Antibody Technology is available on AcquityData.
What sector is GamaMabs Pharma - AMHR2 Antibody Technology in?
GamaMabs Pharma - AMHR2 Antibody Technology operates in the Life Science sector.
Who are the investors in GamaMabs Pharma - AMHR2 Antibody Technology?
Current investors in GamaMabs Pharma - AMHR2 Antibody Technology include Exelixis, Inc.. Sign up to AcquityData to view full investor details, deal dates and transaction history.
How many M&A transactions has GamaMabs Pharma - AMHR2 Antibody Technology been involved in?
GamaMabs Pharma - AMHR2 Antibody Technology has 2 transactions tracked on AcquityData. Sign up to view full investment history including dates, deal sizes, investors and sellers.

Unlock the full GamaMabs Pharma - AMHR2 Antibody Technology profile

Ownership & Investors M&A History Financials Key Executives Advisors & Lenders

Access GamaMabs Pharma - AMHR2 Antibody Technology's complete ownership history, M&A activity, investors, advisors and executives in one connected platform.

Start Free Trial